NCT06604468 A Portable Thoracic Impedance Device for Detecting Pulmonary Congestion in Heart Failure Patients
| NCT ID | NCT06604468 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre hospitalier de l'Université de Montréal (CHUM) |
| Condition | Heart Failure |
| Study Type | OBSERVATIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-09-01 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30 participants in total. It began in 2025-09-01 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study investigates a portable thoracic bioimpedance tomography (TBIT) device designed to detect early lung congestion in heart failure patients. The main goal is to evaluate how well the device's measurements match those obtained from lung ultrasound and other imaging techniques. By detecting lung fluid build-up before symptoms worsen, this device could help manage heart failure more effectively outside of hospital settings, potentially improving patient care and reducing hospital admissions. Participants in the study are monitored using this device along with standard imaging methods, and data on heart failure symptoms are collected to understand the device\'s accuracy and usability.
Eligibility Criteria
Inclusion Criteria: * Adults aged 18 years or older. * Diagnosed with heart failure, defined by the following criterion: hospitalization or an emergency visit for decompensated heart failure (pulmonary edema) within the last 12 months. Exclusion Criteria: * Pregnant women at the time of eligibility evaluation. * Presence of an implanted electronic device in the thorax, such as a pacemaker or defibrillator. * Inability to provide informed consent. * Admission to intensive care or the coronary care unit.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06604468 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Heart Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06604468 currently recruiting?
Yes, NCT06604468 is actively recruiting participants. Contact the research team at william.beaubien-souligny.med@ssss.gouv.qc.ca for enrollment information.
Where is the NCT06604468 trial being conducted?
This trial is being conducted at Montreal, Canada.
Who is sponsoring the NCT06604468 clinical trial?
NCT06604468 is sponsored by Centre hospitalier de l'Université de Montréal (CHUM). The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.